Inflammatory arthritis induced by ICIs can persist after therapyOctober 1, 2019Rheumatoid ArthritisLupus & Connective Tissue Diseases
Prior authorizations for infusibles cause delays, toxicitiesSeptember 26, 2019Rheumatoid ArthritisLupus & Connective Tissue DiseasesSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
ACR looks for continued growth in awareness of rheumatic diseases with latest annual campaignSeptember 20, 2019PediatricsRheumatoid ArthritisLupus & Connective Tissue Diseases
Cannabidiol may interact with rheumatologic drugsSeptember 3, 2019Rheumatoid ArthritisPainOsteoarthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patientsAugust 22, 2019Ankylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Digital health and big data: New tools for making the most of real-world evidenceAugust 19, 2019Business of MedicineRheumatoid Arthritis
PROMIS tools provide useful data for managing rheumatology patientsAugust 12, 2019Psoriatic ArthritisRheumatoid ArthritisOsteoarthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisSpondyloarthropathiesPediatrics
Machine-learning model predicts anti-TNF nonresponse in RA patientsAugust 1, 2019Rheumatoid Arthritis
FDA finds increased blood clot, death risk associated with XeljanzJuly 26, 2019Rheumatoid ArthritisPsoriatic Arthritis
Hadlima approved as fourth adalimumab biosimilar in U.S.July 23, 2019Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathiesPediatrics
Filgotinib fares well in RA trial of inadequate methotrexate respondersJuly 22, 2019Rheumatoid Arthritis
